Pathobiology of familial hypercholesterolemic atherosclerosis

Journal of Submicroscopic Cytology and Pathology

Volumn 36, Issue 3-4, 2004, Pages 225-240

  Aliev, G ^a   Castellani, R J ^b   Petersen, R B ^a   Burnstock, G ^c   Perry, G ^a   Smith, M A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Familial hypercholesterolemia; Genetic models; Lipoprotein metabolism

Indexed keywords

ALPHA TOCOPHEROL; ANTILIPEMIC AGENT; ANTIOXIDANT; CALCIUM ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; NIFEDIPINE; PRAVASTATIN; PROBUCOL;

ABDOMINAL AORTA; AORTA INJURY; AORTA INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HYPERLIPIDEMIA; HYPERTENSION; ISOLATED HEART; LIPID METABOLISM; NONHUMAN; PATHOGENESIS; PATHOLOGY; RABBIT; THORACIC AORTA;

ANIMALS; AORTA; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; RABBITS; RECEPTORS, LDL;

EID: 17444417382     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (148)

1. AALTO-SETALA K., HELVE E., KOVANEN P.T. and KONTULA K., 1989. Finnish type of low density lipoprotein receptor gene mutation (FH-Helsinki) deletes exons encoding the carboxy-terminal part of the receptor and creates an internalization-defective phenotype. J. Clin. Invest., 84, 499-505.
2. ALIEV G. and BURNSTOCK G., 1995. Distribution of constitutive and inducible NOS and ET-1 immunoreactivity in thoracic aortic endothelium in WHHL rabbits. Atherosclerosis, 61, 115, 225.
3. ALIEV G. and BURNSTOCK G., 1998. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histol. Histopathol., 13, 797-817.
4. ALIEV G., MIRONOV A., CIRILLO R., MIRONOV A. JR., GORELOVA E. and PROSDOCIMI M., 1993. Evidence for the presence of early atherosclerotic lesions in newborn WHHL rabbits. Atherosclerosis, 101, 17-24.
5. ALIEV G., BODIN P., MIRONOV A. and BURNSTOCK G., 1995a. Impaired constitutive NOS activity by endogenous and exogenous free radicals in endothelial cells (EC) from Watanabe heritable hyperlipidemic (WHHL) rabbits. Protective effect of Morin. Eur. J. Cell Biol., 213, 665.
6. ALIEV G., MIAH S., TURMAINE M. and BURNSTOCK G., 1995b. An ultrastructural and immunocytochemical studies of thoracic aortic endothelium in aged Sprague-Dawley rats. J. Submicrosc. Cytol. Pathol., 27, 477-490.
7. ALIEV G., RAGAZZI E., CIRILLO R., BEVILACQUA C., MIRONOV A., PROSDOCIMI M. and PARO M., 1998. Cryodamage of the vessel wall accelerates the development of atherosclerotic lesions in arterial vessels of Watanabe hyperlipidemic rabbits. J. Submicrosc. Cytol. Pathol., 30, 417-423.
8. ALIEV G., RAGAZZI E., SMITH M.A., MIRONOV A. and PERRY G., 1999. Morphological features of regeneration of rabbit aortic endothelium after cryoinduced vascular damage. J. Submicrosc. Cytol. Pathol., 31, 495-502.
9. ALIEV G., SHI J., PERRY G., FRIEDLAND R.P. and LAMANNA J.C., 2000. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of Donryu rats on a cholesterol-enriched diet. Anat. Rec., 260, 16-25.
10. ALIEV G., SMITH M.A., TURMAINE M., NEAL M.L., ZIMINA T.V., FRIEDLAND R.P., PERRY G., LAMANNA J.C. and BURNSTOCK G., 2001. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimai cells of hyperlipidemic Watanabe rabbits. Exp. Mol. Pathol., 71, 40-54.
11. AMANUMA K., KANASEKI T., IKEUCHI Y., OHKUMA S. and TAKANO T., 1986. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta of WHHL rabbits. Virchows Arch. A Pathol. Anat. Histopathol., 410, 231-238.
12. BENDITT E.P. and BENDITT J.M., 1973. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A., 70, 1753-1756.
13. BERRY C.L., 1988. The lesion of atherosclerosis. In: Diseases of the Arterial Wall. Camilleri J.P., Berry C.L., Fiessinger J.N. and Barriety J. eds., Springer Verlag, pp. 163-166.
14. BILHEIMER D.W., STONE N.J. and GRUNDY S.M., 1979. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. J. Clin. Invest., 64, 524-533.
15. BILHEIMER D.W., WATANABE Y. and KITA T., 1982. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A., 79, 3305-3309.
16. BOWEN-POPE D.F. and ROSS R., 1982. Platelet-derived growth factor. II. Specific binding to cultured cells. J. Biol. Chem., 257, 5161-5171.
17. BRECHER P., CHAN C.T., FRANZBLAU C., PARIS B. and CHOBANIAN A.V., 1978. Effects of hypertension and its reversal on aortic metabolism in the rat. Circ. Res., 43, 561-569.
18. BRESLOW J.L., 1989. Genetic basis of lipoprotein disorders. J. Clin. Invest., 84, 373-380.
19. BROWN M.S. and GOLDSTEIN J.L., 1975a. Familial hypercholesterolemia: genetic, biochemical and pathophysiologic considerations. Adv. Intern. Med., 20, 273-296.
20. BROWN M.S. and GOLDSTEIN J.L., 1975b. Lipoprotein receptors and genetic control of cholesterol metabolism in cultured human cells. Naturwissenschaften, 62, 385-389.
21. BROWN M.S., DANA S.E. and SIPERSTEIN M.D., 1974. Properties of 3-hydroxy-3-methylglutaryl coenzyme A reductase solubilized from rat liver and hepatoma. J. Biol. Chem., 249, 6585-6589.
22. BROWN M.S., GOLDSTEIN J.L., BROWN M.S. and GOLDSTEIN J.L., 1990. Lipoprotein receptors: therapeutic implications to atherosclerosis. Scavenging for receptors. J. Hypertens. Suppl., 8, S33-S35.
23. BUJA L.M., KOVANEN P.T. and BILHEIMER D.W., 1979. Cellular pathology of homozygous familial hypercholesterolemia. Am. J. Pathol., 97, 327-357.
24. BUJA L.M., KITA T., GOLDSTEIN J.L., WATANABE Y. and BROWN M.S., 1983. Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis, 3, 87-101.
25. BUJA L.M., CLUBB F.J. JR., BILHEIMER D.W. and WILLERSON J.T., 1990. Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur. Heart J., 11 (Suppl. E), 41-52.
26. BUJA L.M., VANWINKLE W.B., SNUGGS M.B. and DE HOSTOS E.L., 2003. Is inflammation the critical factor linking vulnerable coronary plaques to clinical coronary disease? Am. J. Med., 114, 607-608.
27. BUTLER M.M., CLUBB F.J. JR., STEGNER J.G., WILLERSON J.T. and BUJA L.M., 1987. Surface distribution of leukocytes and foam cells in young Watanabe heritable hyperlipidemic (WHHL) rabbit aortas. Fed. Proc., 46, 977.
28. CAMEJO G., 1982. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. Adv. Lipid Res., 19, 1-53.
29. CAREW T.E., SCHWENKE D.C. and STEINBERG D., 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. U.S.A., 84, 7725-7729.
30. CAVALLERO C., TUROLLA E. and RICEVUTI G., 1971. Cell proliferation in the atherosclerotic plaques of cholesterol-fed rabbits. 1. Colchicine and (3H)thymidine studies. J. Intern. Med., 13, 9-20.
31. CHINELLATO A. and RAGAZZI E., 1995. Receptor-mediated pathways of endothelium activity in experimental atherosclerosis. Pharmacol. Res., 31, 163-168.
32. CHINELLATO A., RAGAZZI E., PANDOLFO L., ALVANO A.P., FROLDI G., DE BIASI M., CAPARROTTA L., ALIEV G. and FASSINA G., 1994. Functional and morphologic characterization of thoracic aorta in heritable hyperlipidemic Yoshida rats of different ages. J. Cardiovasc. Pharmacol., 24, 216-228.
33. CHOBANIAN A.V., 1983. The influence of hypertension and other hemodynamic factors in atherogenesis. Prog. Cardiovasc. Dis., 26, 177-196.
34. CHOBANIAN A.V., 1986a. Antihypertensive therapy in evolution. N. Engl. J. Med., 314, 1701-1702.
35. CHOBANIAN A.V., 1986b. Hypertension, antihypertensive drugs, and atherogenesis. Mechanisms and clinical implications. J. Clin. Hypertens., 2, 148S-157S.
36. CHOBANIAN A.V., 1990a. 1989. Corcoran Lecture: Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension, 15, 666-674.
37. CHOBANIAN A.V., 1990b. The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis. Clin. Cardiol., 13, VII43-VII48.
38. CHOBANIAN A.V., 1997. Use of surrogate or intermediate endpoints for assessing the effects of hypertension on atherosclerosis and its complications in man. Blood Press Suppl., 2, 103-107.
39. CHOBANIAN A.V., LICHTENSTEIN A.H., NILAKHE V., HAUDENSCHILD C.C., DRAGO R. and NICKERSON C., 1989. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension, 14, 203-209.
40. CIRILLO R., ALIEV G., ITALIANO G. and PROSDOCIMI M., 1992. Functional responses of hindlimb circulation in aged normal and WHHL rabbits. Atherosclerosis, 93, 133-144.
41. CLOWES A.W. and SCHWARTZ S.M., 1985. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res., 56, 139-145.
42. CLOZEL J.P., LENGSFELD H., KUHN H. and BAUMGARTNER H.R., 1988. Decreased coronary vascular reserve in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis, 8, 310-320.
43. CLUBB F.J. JR., SCHMITZ J.M., BUTLER M.M., BUJA L.M., WILLERSON J.T. and CAMPBELL W.B., 1989. Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis, 9, 529-537.
44. DEUEL T.F., SENIOR R.M., HUANG J.S. and GRIFFIN G.L., 1982. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest., 69, 1046-1049.
45. DICORLETO P.E., GAJDUSEK C.M., SCHWARTZ S.M. and ROSS R., 1983. Biochemical properties of the endothelium-derived growth factor: comparison to other growth factors. J. Cell Physiol., 114, 339-345.
46. DILL L.V. and ISENHOUR C., 1942. Occurrence of atheroma in the aorta in rabbit with renal hypertension. Arch. Pathol., 33, 655-670.
47. FAGGIOTTO A. and ROSS R., 1984. Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis, 4, 341-356.
48. FAGGIOTTO A., ROSS R. and HARKER L., 1984. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis, 4, 323-340.
49. FINCKH B., NIENDORF A., RATH M. and BEISIEGEL U., 1991. Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect? Eur. J. Clin. Pharmacol., 40 (suppl. 1), S77-S80.
50. FLORENTIN R.A., NAM S.C., LEE K.T., LEE K.J. and THOMAS W.A., 1969. Increased mitotic activity in aortas of swine after three days of cholesterol feeding. Arch. Pathol., 88, 463-469.
51. FOGELMAN A.M., SHECHTER I., SEAGER J., HOKOM M., CHILD J.S. and EDWARDS P.A., 1980. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. U.S.A., 77, 2214-2218.
52. GERRITY R.G., 1981a. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol., 103, 181-190.
53. GERRITY R.G., 1981b. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol., 103, 191-200.
54. GERRITY R.G., GOSS J.A. and SOBY L., 1985. Control of monocyte recruitment by chemotactic factor(s) in lesion-prone areas of swine aorta. Arteriosclerosis, 5, 55-66.
55. GLENN K.C. and ROSS R., 1981. Human monocyte-derived growth factor(s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A. Cell, 25, 603-615.
56. GOLDSTEIN J.L. and BROWN M.S., 1977. Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism, 26, 1257-1275.
57. GOLDSTEIN J.L., KITA T. and BROWN M.S., 1983. Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia. N. Engl. J. Med., 309, 288-296.
58. GOWN A.M., TSUKADA T. and ROSS R., 1986. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol., 125, 191-207.
59. GROTENDORST G.R., CHANG T., SEPPA H.E., KLEINMAN H.K. and MARTIN G.R., 1982. Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells. J. Cell Physiol., 113, 261-266.
60. GRUNDY S.M., 1986. Cholesterol and coronary heart disease. A new era. JAMA, 256, 2849-2858.
61. HATANAKA K., ITO T., SHIOMI M., YAMAMOTO A. and WATANABE Y., 1987. Ischemic heart disease in the WHHL rabbit: a model for myocardial injury in genetically hyperlipidemic animals. Am. Heart J., 113, 280-288.
62. HAUDENSCHILD C.C., PRESCOTT M.F. and CHOBANIAN A.V., 1981. Aortic endothelial and subendothelial cells in experimental hypertension and aging. Hypertension, 3, I148-I153.
63. HAUDENSCHILD C.C., GRUNWALD J. and CHOBANIAN A.V., 1985. Effects of hypertension on migration and proliferation of smooth muscle in culture. Hypertension, 7, 1101-1104.
64. HAVEL R.J., KITA T., KOTITE L., KANE J.P., HAMILTON R.L., GOLDSTEIN J.L. and BROWN M.S., 1982. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. Arteriosclerosis, 2, 467-474.
65. IMAI H., LEE K.T., PASTORI S., PANLILIO E., FLORENTIN R. and THOMAS W.A., 1966. Atherosclerosis in rabbits. Architectural and subcellular alterations of smooth muscle cells of aortas in response to hyperlipemia. Exp. Mol. Pathol., 5, 273-310.
66. JEROME W.G. and LEWIS J.C., 1984. Early atherogenesis in White Carneau pigeons. I. Leukocyte margination and endothelial alterations at the celiac bifurcation. Am. J. Pathol., 116, 56-68.
67. JEROME W.G. and LEWIS J.C., 1985. Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations. Am. J. Pathol., 119, 210-222.
68. JOKINEN M.P., CLARKSON T.B. and PRICHARD R.W., 1985. Animal models in atherosclerosis research. Exp. Mol. Pathol., 42, 1-28.
69. JORIS I., ZAND T., NUNNARI J.J., KROLIKOWSKI F.J. and MAJNO G., 1983. Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats. Am. J. Pathol., 113, 341-358.
70. KARINO T., 1986. Microscopic structure of disturbed flows in the arterial and venous systems, and its implication in the localization of vascular diseases. Int. Angiol., 5, 297-313.
71. KARINO T. and GOLDSMITH H.L., 1985. Particle flow behavior in models of branching vessels. II. Effects of branching angle and diameter ratio on flow patterns. Biorheology, 22, 87-104.
72. KASKI J.C., CREA F., MERAN D., RODRIGUEZ L., ARAUJO L., CHIERCHIA S., DAVIES G. and MASERI A., 1986. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. J. Am. Coll. Cardiol., 74, 1255-1265.
73. KITA T., BROWN M.S., WATANABE Y. and GOLDSTEIN J.L., 1981. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A., 78, 2268-2272.
74. KITA T., BROWN M.S., BILHEIMER D.W. and GOLDSTEIN J.L., 1982. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc. Natl. Acad. Sci. U.S.A., 79, 5693-5697.
75. KITA T., NAGANO Y., YOKODE M., ISHII K., KUME N., OOSHIMA A., YOSHIDA H. and KAWAI C., 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. U.S.A., 84, 5928-5931.
76. KLEINVELD H.A., DEMACKER P.N. and STALENHOEF A.F., 1994. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb., 14, 1386-1391.
77. KOLODGIE F.D., VIRMANI R., RICE H.E. and MERGNER W.J., 1990. Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits. Circ. Res., 66, 1112-1126.
78. KONDO T. and WATANABE Y., 1975. A heritable hyperlipemic rabbit. Jikken Dobutsu, 24, 89-94.
79. KROON A.A., STALENHOEF A.F., BUIKEMA H., DEMACKER P.N., DE WILDE P.C., LEIJTEN P.A. and VAN GILST W.H., 1993. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits. J. Intern. Med., 103, 221-230.
80. LICHTENSTEIN A.H. and CHOBANIAN A.V., 1990. Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit. Arteriosclerosis, 10, 597-606.
81. MAHLEY R.W., 1979. Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim. Biophys. Acta, 575, 81-91.
82. MAHLEY R.W., 1985. Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. J. Am. Coll. Cardiol., 72, 943-948.
83. MAHLEY R.W., INNERARITY T.L., RALL S.C. JR. and WEISGRABER K.H., 1985. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia. Ann. N. Y. Acad. Sci., 454, 209-221.
84. MALCZAK H.T. and BUCK R.C., 1977. Regeneration of endothelium in rat aorta after local freezing. A scanning electron microscopic study. Am. J. Pathol., 86, 133-148.
85. MCGILL H.J., CAREY K.D., MCMAHAN C.A., MARINEZ Y.N., COOPER T.E., MOTT G.E. and SCHWARTZ C.J., 1985. Effects of two forms of hypertension on atherosclerosis in the hyperlipidemic baboon. Arteriosclerosis, 5, 481-493.
86. MCMILLAN G.C. and DUFF G.L., 1948. Mitotic activity in the aortic lesions of experimental atherosclerosis in rabbits. Arch. Pathol., 46, 179-182.
87. MCMILLAN G.C. and STARY H.C., 1968. Preliminary experience with mitotic activity of cellular elements in the atherosclerotic plaques of cholesterol-fed rabbits studied by labeling with tritiated thymidine. Ann. N. Y. Acad. Sci., 149, 699-709.
88. MIRONOV A.A., MIRONOV V.A. and REKHTER M.D., 1985. Changes in the endothelium of the aorta of the rat during regeneration (according to the results of scanning electron microscopy). Arkh. Anat. Gistol. Embriol., 89, 54-60.
89. MIRONOV, A.A., MIRONOV V.A., REKHTER M.D. and VYALOV S.L., 1988a. Regeneration of arterial and venous endothelium. Anat. Anz., 8, 709-710.
90. MIRONOV V.A., MIRONOV A.A., BOBYREV V.N. and VOSKRESENSKII O.N., 1988b. Ultrastructure of the inner surface of the aorta of mature and old animals. Arkh. Anat. Gistol. Embriol., 94, 23-26.
91. MORI Y., WADA H., NAGANO Y., DEGUCHI K., KITA T. and SHIRAKAWA S., 1989. Hypercoagulable state in the Watanabe heritable hyperlipidemic rabbit, an animal model for the progression of atherosclerosis. Effect of probucol on coagulation. Thromb. Haemost., 61, 140-143.
92. PARO M., CIRILLO R., SALVATICO E., ALIEV G., PROSDOCIMI M., SOLDA P. and PANTALEO E., 1991. Vascular hemodynamic impedance and cardiac output are altered in genetic model of atherosclerosis (WHHL rabbits). In: Abstr. Book, IX International Symposium of Atherosclerosis, Chicago, USA, 2125.
93. PARO M., CIRILLO R., ALIEV G., PROSDOCIMI M., SOLDA P., PERLINI S. and BERNARDI L., 1992. Vascular hemodynamic impedance and cardiac output in aged WHHL rabbits: Pharmacological characterization. In: Abstr. Book of the Scientific Sessions of the American Heart Association, Scientific Conference on Function and Structural Mechanisms of Vascular Control, 40.
94. RAGAZZI E., CHINELLATO A., DE BIASI M., PANDOLFO L., PROSDOCIMI M., NORIDO F., CAPARROTTA L. and FASSINA G., 1989. Endothelium-dependent relaxation, cholesterol content and high energy metabolite balance in Watanabe hyperlipemic rabbit aorta. Atherosclerosis, 80, 125-134.
95. RAGAZZI E., CHINELLATO A., PANDOLFO L., FROLDI G., CAPARROTTA L., PROSDOCIMI M., ALIEV G. and FASSINA G., 1993. Atherosclerosis-related remodelling of aortic relaxation to purines in the Watanabe heritable hyperlipidemic rabbit. J. Pharmacol. Exp. Ther., 266, 1091-1096.
96. RAGAZZI E., CHINELLATO A., PANDOLFO L., FROLDI G., CAPARROTTA L., ALIEV G., PROSDOCIMI M. and FASSINA G., 1995. Endothelial nucleotide-mediated aorta relaxation in aged Watanabe heritable hyperlipidemic rabbits. J. Cardiovasc. Pharmacol., 26, 119-126.
97. RALEVIC V., ALIEV G. and BURNSTOCK G., 1996. Mesenteric and hepatic vascular reactivity in Donryu rats with and without a cholesterol-supplemented diet. Eur. J. Pharmacol., 313, 221-227.
98. REIDY M.A. and SCHWARTZ S.M., 1983. Endothelial injury and regeneration. IV. Endotoxin: a nondenuding injury to aortic endothelium. Lab. Invest., 48, 25-33.
99. REIDY M.A., REIDY M.A., SILVER M., HARLAN J.M., SCHWARTZ B.R., REIDY M.A., SCHWARTZ S.M., OCHS H.D., HARKER L.A., CLOWES A.W., GOWN A.M., HANSON S.R. and REIDY M.A., 1985. A reassessment of endothelial injury and arterial lesion formation. Lab. Invest., 53, 513-520.
100. REKHTER M.D. and MIRONOV A.A., 1987. Morphological signs of reparative regeneration of the aortic endothelium undergoing repeated injuries. Biull. Eksp. Biol. Med., 103, 98-101.
101. REKHTER M.D., ANDREEVA E.R., MIRONOV A.A. and OREKHOV A.N., 1991. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am. J. Pathol., 138, 569-580.
102. ROBERTS W.C., FERRANS V.J., LEVY R.I. and FREDRICKSON D.S., 1973. Cardiovascular pathology in hyperlipoproteinemia. Anatomic observations in 42 necropsy patients with normal or abnormal serum lipoprotein patterns. Am. J. Cardiol., 31, 557-570.
103. ROBERTSON W.B. and STRONG J.P., 1968. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest., 18, 538-551.
104. ROSENFELD M.E. and ROSS R., 1990. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 10, 680-687.
105. ROSENFELD M.E., TSUKADA T., CHAIT A., BIERMAN E.L., GOWN A.M. and ROSS R., 1987a. Fatty streak expansion and maturation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 7, 24-34.
106. ROSENFELD M.E., TSUKADA T., GOWN A.M. and ROSS R., 1987b. Fatty streak initiation in Watanabe heritable hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis, 7, 9-23.
107. ROSENFELD M.E., PALINSKI W., YLA-HERTTUALA S., BUTLER S. and WITZTUM J.L., 1990a. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis, 10, 336-349.
108. ROSENFELD M.E., PALINSKI W., YLA-HERTTUALA S. and CAREW T.E., 1990b. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis. Toxicol. Pathol., 18, 560-571.
109. ROSS R., 1986. The pathogenesis of atherosclerosis - an update. N. Engl. J. Med., 314, 488-500.
110. ROSS R., 1993. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol., 143, 987-1002.
111. RUBANYI G.M., 1988. Vascular effects of oxygen-derived free radicals. Free Radic. Biol. Med., 4, 107-120.
112. RUBANYI G.M., 1993. The role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol., 22 (Suppl. 4), S1-S14.
113. SCHROEDER J.S., BOLEN J.L., QUINT R.A., CLARK D.A., HAYDEN W.G., HIGGINS C.B. and WEXLER L., 1977. Provocation of coronary spasm with ergonovine maleate. New test with results in 57 patients undergoing coronary arteriography. Am. J. Cardiol., 40, 487-491.
114. SCHWARTZ S.M. and BENDITT E.P., 1977. Aortic endothelial cell replication. I. Effects of age and hypertension in the rat. Circ. Res., 41, 248-255.
115. SCHWARTZ S.M., FOY L., BOWEN-POPE D.F. and ROSS R., 1990. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am. J. Pathol., 136, 1417-1428.
116. SCOTT R.F., DAOUD A.S. and FLORENTIN R.A., 1971. Animal models in atherosclerosis. In: 'The Pathogenesis of Atherosclerosis'. Wissler R.W. and Geer J.C. eds., Baltimore, Williams and Wilkins, 120-146.
117. SHEPHERD J.T. and VANHOUTTE P.M., 1986. Mechanisms responsible for coronary vasospasm. J. Am. Coll. Cardiol., 8, 50A-54A.
118. SHIMOKADO K., RAINES E.W., MADTES D.K., BARRETT T.B., BENDITT E.P. and ROSS R., 1985. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell, 43, 277-286.
119. SIMIONESCU M. and SIMIONESCU N., 1993. Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J., 7, 1359-1366.
120. SIMIONESCU N., VASILE E., LUPU F., POPESCU G. and SIMIONESCU M., 1986. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. Am. J. Pathol., 123, 109-125.
121. 3H autoradiography. Circ. Res., 11, 329-336.
122. STAMLER J. and SHEKELLE R., 1988. Dietary cholesterol and human coronary heart disease. The epidemiologic evidence. Arch. Pathol. Lab Med., 112, 1032-1040.
123. STARY H.C., 1975. Nonhuman primate models in cardiovascular research: analysis of the 1974 Scientific Sessions of the American Heart Association. J. Med. Primatol., 4, 274-277.
124. STARY H.C. and MCMILLAN G.C., 1970. Kinetics of cellular proliferation in experimental atherosclerosis. Radioautography with grain counts in cholesterol-fed rabbits. Arch. Pathol., 89, 173-183.
125. STEIN Y., STEIN O., DELPLANQUE B., FESMIRE J.D., LEE D.M. and ALAUPOVIC P., 1989. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. J. Intern. Med., 75, 145-155.
126. STEINBERG D., PARTHASARATHY S. and CAREW T.E., 1988. In vivo inhibition of foam cell development by probucol in Watanabe rabbits. Am. J. Cardiol., 62, 6B-12B.
127. STEINBERG D., PARTHASARATHY S., CAREW T.E., KHOO J.C. and WITZTUM J.L., 1989. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl. J. Med., 320, 915-924.
128. TANZAWA K., SHIMADA Y., KURODA M., TSUJITA Y., ARAI M. and WATANABE H., 1980. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett., 118, 81-84.
129. THANNHAUSER S.J., 1958. Lipidoses, diseases of intracellular lipid metabolism. In: Lipidoses, Diseases of Intracellular Lipid Metabolism. New York, Grune and Stratton, 3rd Ed., 102-151.
130. THOMAS W.A., REINER J.M., FLORENTIN R.A. and SCOTT R.F., 1979. Population dynamics of arterial cells during atherogenesis. VIII. Separation of the roles of injury and growth stimulation in early aortic atherogenesis in swine originating in pre-existing intimal smooth muscle cell masses. Exp. Mol. Pathol., 31, 367-386.
131. TILTON G.D., BUJA L.M., BILHEIMER D.W., APPRILL P., ASHTON J., MCNATT J., KITA T. and WILLERSON J.T., 1985. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. J. Am. Coll. Cardiol., 6, 141-144.
132. TSUKADA T., ROSENFELD M., ROSS R. and GOWN A.M., 1986. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis, 6, 601-613.
133. VAN NIEKERK J.L., HENDRIKS T., DE BOER H.H. and VAN 'T L.A., 1984a. Does nifedipine suppress atherogenesis in WHHL rabbits? J. Intern. Med., 53, 91-98.
134. VAN NIEKERK J.L., HENDRIKS T., GEVERS LEUVEN J.A., HAVEKES L. and DE BOER H.H., 1984b. The lipid-lowering effects of 3-hydroxy-3-methylglutaric acid and bile acid drainage in WHHL rabbits. Clin. Sci. (London), 67, 439-444.
135. VESSELINOVITCH D., 1979. Animal models of atherosclerosis, their contributions and pitfalls. Artery, 5, 193-206.
136. VESSELINOVITCH D., 1988. Animal models and the study of atherosclerosis. Arch. Pathol. Lab Med., 112, 1011-1017.
137. VIJAYAGOPAL P., SRINIVASAN S.R., JONES K.M., RADHAKRISHNAMURTHY B. and BERENSON G.S., 1985. Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. Biochim. Biophys. Acta, 837, 251-261.
138. VIKHERT A.M. and ZHDANOV V.S., 1989. Role of rhythmic structures of aortic intima in the development of atherosclerosis. Zentrabl. Allg. Pathol., 135, 607-617.
139. WALKER L.N., BOWEN-POPE D.F., ROSS R. and REIDY M.A., 1986a. Morphology and cell kinetics of fatty streak lesion formation in the hypercholesterolemic rabbit. Am. J. Pathol., 125, 450-459.
140. WALKER L.N., BOWEN-POPE D.F., ROSS R. and REIDY M.A., 1986b. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc. Natl. Acad. Sci. U.S.A., 83, 7311-7315.
141. WATANABE N., ISHIKAWA Y., OKAMOTO R., WATANABE Y. and FUKUZAKI H., 1987. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits. Artery, 14, 283-294.
142. WATANABE Y., 1980. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). J. Intern. Med., 36, 261-268.
143. WATANABE Y., ITO T., SAEKI M., KURODA M., TANZAWA K., MOCHIZUKI M., TSUJITA Y. and ARAI M., 1981. Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia. J. Intern. Med., 38, 27-31.
144. WATANABE Y., ITO T. and SHIOMI M., 1985. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits. An animal model for familial hypercholesterolemia. J. Intern. Med., 56, 71-79.
145. WIENER J., LATTES R.G., MELTZER B.G. and SPIRO D., 1969. The cellular pathology of experimental hypertension. IV. Evidence for increased vascular permeability. Am. J. Pathol., 54, 187-207.
146. WILKINS R.H., ROBERTS J.C. JR. and MOCES C., 1959. Autopsy studies in atherosclerosis. III. Distribution and severity of atherosclerosis in the presence of obesity, hypertension, nephrosclerosis and rheumatic heart disease. Circulation, 20, 527-536.
147. YAMAMOTO T., BISHOP R.W., BROWN M.S., GOLDSTEIN J.L. and RUSSELL D.W., 1986. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science, 232, 1230-1237.
148. YASUE H., HORIO Y., NAKAMURA N., FUJII H., IMOTO N., SONODA R., KUGIYAMA K., OBATA K., MORIKAMI Y. and KIMURA T., 1986. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. J. Am. Coll. Cardiol., 74, 955-963.